LONDON, July 5, 2026, 23:01 BST
- Zotefoams closed Friday at 455p, rising 4.12% for the session and gaining 8.6% compared to last Friday.
- Trading over five sessions came to roughly 412,000 shares, below 1% of shares outstanding.
- May’s trading update showed four-month revenue at £64.1 million, roughly a third of the full-year market revenue target the company mentioned.
- The financial calendar says the company’s next event is interim results in August.
The London market is closed Sunday, so Zotefoams plc (LON:ZTF) last traded Friday. Hargreaves Lansdown priced the shares at 455p, up 18p or 4.12% after hours, with a 453p sell and 459p buy. The FTSE All-Share rose 0.28% that day.
There wasn’t much fresh company news over the weekend. Zotefoams’ news site hasn’t posted anything new since a June 30 update, and ADVFN’s RNS feed still shows the most recent regulatory news as a June 17 director/PDMR notification.
Turnover is the real concern for investors, more than price. Zotefoams climbed 36p from where it closed on June 26 to last Friday, but in the five sessions from June 29 to July 3, about 412,000 shares traded. That’s only about 0.8% of the equity, based on Google Finance’s count of 49.65 million shares outstanding.
| Date | Close | Day change | Volume |
|---|---|---|---|
| Jun. 26 | 419.00p | -0.71% | 130.80k |
| Jun. 29 | 423.00p | +0.95% | 125.51k |
| Jun. 30 | 440.00p | +4.02% | 84.10k |
| Jul. 1 | 437.00p | -0.68% | 51.69k |
| Jul. 2 | 437.00p | flat | 46.14k |
| Jul. 3 | 455.00p | +4.12% | 104.56k |
This is key since small-cap shares can swing when news is thin and trading is tight. Next up is seeing if first-half results support the share price, or if it’s just movement between the bid and offer.
Zotefoams said in its May 27 update that revenue for the four months to April 30 climbed 26% to £64.1 million. EMEA sales gained 24% to £50.1 million, with OKC accounting for £9.8 million. North America revenue increased 30% organically to £12.1 million. Asia brought in £1.9 million, about double last year. Chief Executive Ronan Cox said “growth delivered despite increased macro volatility.” The board kept its guidance for the year. Zotefoams
| Measure | Four months to Apr. 30 | Comparison |
|---|---|---|
| Group revenue | £64.1 mln | Up 26% from a year ago |
| EMEA revenue | £50.1 mln | Rose 24%; OKC was £9.8 mln |
| North America revenue | £12.1 mln | Up 30% organic |
| Asia revenue | £1.9 mln | About two times higher |
| FY 2026 market revenue expectation cited by company | £190.8 mln | April year-to-date was 33.6% of that target |
Zotefoams traded at 455p, up 8.59% for the past five days and 12.90% so far this year, according to MarketScreener. The site showed five analysts on the name, with a consensus rating of “Buy.” The average target price was 613p—about 34.73% above where shares closed on Friday. MarketScreener UK
Zotefoams’ latest update last week was a commercial one. The company said June 30 it named Polyformes as an approved fabricator in EMEA, targeting engineered industrial packaging. “Industrial packaging is a highly technical application,” said Fabrice Lacroix, sales director for EMEA. Zotefoams
The partner programme is important because it suggests growth could come from areas besides footwear. Footwear is seen moderating. The May update flagged that demand in target markets and OKC would likely more than balance this slowdown. The Polyformes news shows investors there’s at least one current sign of growth from outside footwear.
Keep an eye on the cash line. Zotefoams’ 2025 annual report listed revenue at £158.5 million and cash from operations at £39.7 million. Capital expenditure, including intangibles, climbed to £24.6 million, up from £13.3 million in 2024. The bigger spend goes with the Vietnam and South Korea projects mentioned in the May update.
The financial calendar doesn’t list any event for July. It includes August 2026 interim results, an October 2026 interim dividend payment and a March 2027 release of 2026 results, all with provisional dates.
